Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Canadian Solar (NASDAQ:CSIQ) is set to give its latest quarterly earnings report on Tuesday, 2022-05-24. Here's what investors need to know before the announcement. Analysts estimate that Canadian Solar will report an earnings per share (EPS) of $-0.13.

Benzinga

eBay Launches NFT Collection In Partnership With OneOf

eBay Inc (NASDAQ:EBAY) has launched a series of NFTs through a strategic partnership with OneOf, a green NFT platform for communities across music, sports, and lifestyle. The partnership combines eBay's global reach and inventory and OneOf's eco-conscious Web3 technology. eBay's first Genesis NFT Collection will feature 3D and animated interpretations of athletes featured…

Benzinga

If You Invested $100 In TSLA 10 Years Ago, Here's How Much You Would Have Today

Tesla (NASDAQ:TSLA) has outperformed the market over the past 10 years by 47.64% on an annualized basis producing an average annual return of 59.02%. Currently, Tesla has a market capitalization of $679.55 billion.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Looking Into Sovos Brands's Return On Invested Capital

According to Benzinga Pro, during Q1, Sovos Brands (NASDAQ:SOVO) earned $4.06 million, a 205.65% increase from the preceding quarter. Sovos Brands also posted a total of $209.93 million in sales, a 10.93% increase since Q4.

Benzinga

Aligos Therapeutics's Return On Capital Employed Insights

According to Benzinga Pro data, during Q1, Aligos Therapeutics (NASDAQ:ALGS) posted sales of $2.57 million. Earnings were up 5.57%, but Aligos Therapeutics still reported an overall loss of $35.62 million.

Benzinga

Looking Into Liberty Latin America's Return On Invested Capital

According to Benzinga Pro, during Q1, Liberty Latin America (NASDAQ:LILA) earned $93.20 million, a 114.24% increase from the preceding quarter. Liberty Latin America's sales decreased to $1.22 billion, a 4.69% change since Q4.

Benzinga

Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer

Seagen Inc (NASDAQ:SGEN) announced topline results from phase 2 MOUNTAINEER trial investigating Tukysa (tucatinib) in combination with trastuzumab in previously treated HER2-positive metastatic colorectal cancer (mCRC) patients. Trastuzumab is sold under the name Herceptin by Genentech, a unit of Roche Holdings AG (OTC:RHHBY). Data from this trial will form the basis of a planned supplemental…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022

Benzinga

Starbucks Closes Russia Business Permanently: WSJ

Starbucks Corp (NASDAQ:SBUX) is shutting down its business in Russia, the Wall Street Journal reported. The coffee giant has decided to permanently close operations in its 130 stores and would no longer have an operation in Russia. The company had suspended its licensee's Russian business on March 8. The report noted the company…

Benzinga

Mid-Morning Market Update: Markets Mixed; Broadcom In Talks To Buy VMWare

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 250 points on Monday.

Benzinga

Why Kala Pharmaceuticals Shares Are Rising Today

Kala Pharmaceuticals Inc (NASDAQ: KALA) shares are trading higher after the company said it would sell its EYSUVIS and INVELTYS treatments for $60 million.

Benzinga

Mirum Pharma Acquires Its Licensing Partner In Cash and Stock

Mirum Pharmaceuticals Inc (NASDAQ:MIRM) has acquired Satiogen Pharmaceuticals Inc in a cash and stock deal. The deal consideration includes 841,792 shares, 199,993 of which are subject to the achievement of a milestone, and approximately $2.8 million in cash. Mirum will wholly own the Satiogen subsidiary, which will receive a 2% royalty. Satiogen was an…

Benzinga

Capstone Distributor Secures Six Orders For C65 Microturbines

Cal Microturbine, Capstone Green Energy Corp's (NASDAQ:CGRN) exclusive distributor for California, Hawaii, Nevada, Oregon, and Washington, has secured six orders for C65 microturbines throughout the state of California. Financial terms were not disclosed. The 16 C65 units will be installed for customers in the agriculture, oil and gas, and hospitality industries. The systems are…

Benzinga

Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share

Innoviva Inc (NASDAQ:INVA) has agreed to acquire Entasis Therapeutics Holdings Inc (NASDAQ:ETTX) at $2.20 per share in cash. Innoviva currently owns approximately 60% of the outstanding shares of Entasis common stock. The acquisition consideration values Entasis' equity at $113 million on a fully diluted basis. "This acquisition will build upon our overall strategy to acquire differentiated,…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Catalyst Biosciences Stock More Than Doubles After Assets Sale To Vertex

Catalyst Biosciences Inc (NASDAQ:CBIO) has agreed to sell its portfolio of protease medicines that regulate complement to Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for $60 million. "This sale is part of the ongoing strategic process that we announced in February to explore alternatives and create value for shareholders. We have significantly reduced our cash burn and continue…

Benzinga

Why Nymox Pharma Shares Sinking to 52-Week Low?

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) has received a Refusal to File (RTF) letter from FDA regarding its marketing application for Fexapotide Triflutate. Nymox's position is that clarifications remain to be resolved at a follow-up meeting and that some significant inconsistencies were involved. In March, the company submitted a Fexapotide Triflutate application for benign prostatic…

Benzinga

DiDi Investors To Vote On US Delisting

DiDi Global Inc (NYSE:DIDI) shareholders will vote to delist from the NYSE to get its services back on to Chinese app stores for the first time in almost a year. The plan to delist comes almost a year after the company pushed ahead with a $4.4 billion initial public offering in the U.S.…

Benzinga

Here's Why Analysts Are Bullish On Zoom Despite Selloff

Analysts believe that the Zoom Video Communications, Inc (NASDAQ: ZM) selloff may have gone too far.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Catalyst Biosciences Shares Are Skyrocketing Today

Catalyst Biosciences Inc (NASDAQ: CBIO) shares are trading higher by 180.26% at $1.06 after the company announced it sold its complement portfolio for $60 million.

Benzinga

Why SIGA Technologies Stock Is Surging

SIGA Technologies Inc (NASDAQ: SIGA) shares are trading higher Monday morning following increased social media interest amid elevated concerns surrounding a monkeypox outbreak.

Benzinga

This Day In Market History: Netflix Goes Public

Each day, Benzinga takes a look back at a notable market-related moment that occurred on this date. What Happened? On May 23, 2002, Netflix, Inc. (NASDAQ: NFLX) went public.

Benzinga

Ideanomics To Support Coast Counties Peterbilt's Transition To Electric Fleet Vehicles - Read How

Ideanomics Inc (NASDAQ:IDEX) has signed an agreement with Coast Counties Peterbilt to deploy and operate energy and charging solutions at Coast Counties' truck dealerships in California. Financial terms were not disclosed. GridMarket facilitated the project, and Ideanomics was selected as an implementation partner through the GridMarket platform. The agreement includes a Power Purchase…

Benzinga

4 Analysts Have This to Say About Horizon Therapeutics

Horizon Therapeutics (NASDAQ:HZNP) has observed the following analyst ratings within the last quarter:

Benzinga

Expert Ratings for Autodesk

Analysts have provided the following ratings for Autodesk (NASDAQ:ADSK) within the last quarter:

Benzinga

FDA Removes Clinical Hold On Ocugen's COVID Vaccine Trial

The FDA has lifted the clinical hold on Ocugen Inc's (NASDAQ:OCGN) Phase 2/3 trial, OCU-002, for Covaxin (BBV152), a whole virus inactivated COVID-19 vaccine candidate. In April, the agency paused the trials of the shot, Covaxin, after an inspection of a Bharat Biotech facility by the World Health Organization (WHO) revealed deficiencies…

1 … 522 523 524 525

Organisations

World Health Organization

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Intellectual Property

370 stories

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.